Skip to main content

Animations

MJFF Publications

3251 - 3260 of 6255 Results
Title
Year
  • Year
  • 2023
  • 2020
  • 2013
  • 2018
  • 2022
  • 2023
  • 2020
  • 2024
  • 2023
  • 2017
  • Summary Details
    OPEN
    Title: Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13690
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51022
    Citation Count: 67
  • Summary Details
    OPEN
    Title: A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.011940
    Citation Count: 37
  • Summary Details
    OPEN
    Title: TMEM106B haplotypes have distinct gene expression patterns in aged brain
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0268-2
    Citation Count: 37
  • Summary Details
    OPEN
    Title: How Vacations Affect Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13597
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-37464-2
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2020.102391
    Citation Count: 34
  • Summary Details
    OPEN
    Title: A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awae346
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00451-x
    Citation Count: 10
  • Summary Details
    OPEN
    Title: GBA mutations in Parkinson disease: earlier death but similar neuropathological features
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.13395
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.